Schedule 13D ownership disclosure
Arno Therapeutics, Inc
Security class unavailable · CUSIP: 042564203
Event date: 2013-03-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-123223
- Form type
- SC 13D
- Filer
- Arno Therapeutics, Inc
- CIK
- CIK 1195116
- Filed
- Sep 08, 2016
- Reporting period
- Mar 27, 2013
- Description
- Schedule 13D beneficial ownership